File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Article: Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
| Title | Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study |
|---|---|
| Authors | |
| Issue Date | 23-Apr-2025 |
| Publisher | Korean Association for the Study of the Liver |
| Citation | Clinical and Molecular Hepatology, 2025, v. 31, n. 3, p. 1084-1099 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/362739 |
| ISSN | 2023 Impact Factor: 14.0 2023 SCImago Journal Rankings: 3.128 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mao, Xianhua | - |
| dc.contributor.author | Zhang, Xinrong | - |
| dc.contributor.author | Lai, Rongtao | - |
| dc.contributor.author | Cheung, Ka-Shing | - |
| dc.contributor.author | Yuen, Man-Fung | - |
| dc.contributor.author | Cheung, Ramsey | - |
| dc.contributor.author | Seto, Wai Kay | - |
| dc.contributor.author | Nguyen, Mindie H | - |
| dc.date.accessioned | 2025-09-27T00:35:31Z | - |
| dc.date.available | 2025-09-27T00:35:31Z | - |
| dc.date.issued | 2025-04-23 | - |
| dc.identifier.citation | Clinical and Molecular Hepatology, 2025, v. 31, n. 3, p. 1084-1099 | - |
| dc.identifier.issn | 2287-2728 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/362739 | - |
| dc.language | eng | - |
| dc.publisher | Korean Association for the Study of the Liver | - |
| dc.relation.ispartof | Clinical and Molecular Hepatology | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.title | Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.3350/cmh.2024.1096 | - |
| dc.identifier.volume | 31 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.spage | 1084 | - |
| dc.identifier.epage | 1099 | - |
| dc.identifier.eissn | 2287-285X | - |
| dc.identifier.issnl | 2287-2728 | - |

